LKT Labs

Biochemicals for Life Science Research

Saracatinib

Saracatinib

Product ID S0168
Cas No. 379231-04-6
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $33.10 In stock
5 mg $49.70 In stock
25 mg $165.40 In stock
Bulk Quote

Quicklinks

Description

Saracatinib is an inhibitor of Src and Abl family kinases that is used for its anticancer chemotherapeutic and immunomodulatory benefits. Saracatinib is currently in clinical trials as a potential treatment for a variety of cancers, including non-small cell lung cancer (NSCLC), pancreatic cancer, gastric cancer, and myeloma. In cellular and animal models, this compound inhibits migration, invasion, and growth of cancer cells. Additionally, saracatinib displays mixed immunomodulatory effects, decreasing T cell cytokine production in one in vitro model and increasing CD8+ memory T cells and production of IFN-γ in another in vitro model.

Product Info

Cas No.

379231-04-6
Purity

≥98%
Formula

C27H32ClN5O5
Formula Wt.

542.03
Chemical Name

N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine
IUPAC Name

N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine
Synonym

AZD-0530
Appearance

Off white powder

Shipping and Storage

Store Temp

Ambient
Ship Temp

Ambient

Downloads

MSDS

S0168 MSDS PDF
Info Sheet

S0168 Info Sheet PDF

References

Gangadhar TC, Clark JI, Karrison T, et al. Phase II study of the Src kinase inhibitor saracatinib (AZD0530) in metastatic melanoma. Invest New Drugs. 2013 Jun;31(3):769-73. PMID: 23151808.

Nam HJ, Im SA, Oh DY, et al. Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer. Mol Cancer Ther. 2013 Jan;12(1):16-26. PMID: 23144237.

Cavalloni G, Peraldo-Neia C, Sarotto I, et al. Antitumor activity of Src inhibitor saracatinib (AZD-0530) in preclinical models of biliary tract carcinomas. Mol Cancer Ther. 2012 Jul;11(7):1528-38. PMID: 22452946.

Takai S, Sabzevari H, Farsaci B, et al. Distinct effects of saracatinib on memory CD8+ T cell differentiation. J Immunol. 2012 May 1;188(9):4323-33. PMID: 22450814.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • I0933

    Icilin

    TRPM8 activator, TRPV3 blocker.
    ≥98%
  • A0978

    Actinonin

    Peptide deformylase, MMP meprin A, aminopeptidase ...
    ≥98%
  • D336486

    Dimethylamino Parthenolide

    Water-soluble parthenolide analog; NF-κB inhibito...
    ≥98%
  • G7346

    GSK-2636771

    p110β PI3K inhibitor.
    ≥98%
  • S0032

    Saikosaponin B1

    Saponin found in Bupleurum, Heteromorpha, and Scro...
    ≥98%
  • P7359

    Psoralidin

    Phenol found in Psoralea coryfolia.
    ≥98%
  • S0254

    Sanguinarine Chloride

    Decreases expression of MMPs, PGE2, and COX-2, and...
    ≥98%
  • B1654

    Benzyl Selenocyanate

    Organoselenium compound found in selenium-enriched...
    ≥98%
  • I7460

    R-1-Isothiocyanato-8-(methylsulfinyl)-octane

    ITC found in Nasturtium officinale.
    ≥98%
  • O9497

    Oxytocin

    Endogenous neuropeptide hormone, involved in socia...
    ≥95%
  • C0149

    Calcitonin, salmon

    Endogenous neuropeptide hormone, lowers extracellu...
    ≥98%
  • D5747

    Dolasetron Mesylate Hydrate

    5-HT3 antagonist.
    ≥98%
  • N1987

    Neuropeptide Y (13-36), human

    Endogenous peptide neurotransmitter, involved in f...
    ≥95%
  • D3322

    Diflunisal

    NSAID; COX-1/2 inhibitor.
    ≥98%
  • F1670

    Ferulic Acid Methyl Ester

    Hydroxycinnamic aicd, verbascoside metabolite, ion...
    ≥98%
  • V0153

    Vanilloid Receptor 1 Fragment

    Peptide fragment of TRPV1.
    ≥95%
  • G3354

    Ginkgolide A

    Terpene lactone found in Ginkgo; GSK-3β inhibitor...
    ≥95%
  • A1592

    ADX-47273

    mGluR5 positive modulator.
    ≥98%
  • N1610

    Necrostatin-1

    RIP1 inhibitor.
    ≥99%
  • R8122

    Rufloxacin Hydrochloride

    Fluoroquinolone; topoisomerase IV and bacterial DN...
    ≥98%